STAT+: Braced for details on Trump’s ‘most favored nation’ policy, pharma industry is still waiting
Braced for details on President Trump’s "most favored nation' policy, the pharma industry is still waiting.
WASHINGTON — Executives at pharmaceutical companies have been bracing for more information from the Trump administration this week about how it planned to lower drug prices.
That information has not yet arrived, despite the administration’s self-imposed deadline to disclose by Wednesday the target prices for drugs, part of its plan to ensure Americans would pay no more than the lowest price for drugs paid by peer nations.
The task was to be carried out by health secretary Robert F. Kennedy Jr., according to an executive order released by President Trump last month. Asked when the “price targets” would be issued, a White House spokesperson told STAT in an email that they already had been.
